External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CMSC 2022

-
Coming soon
03:50 PM
Duration 20mins Gaylord National Resort & Convention Center Potomac C
Demographics and Baseline Disease Characteristics of Black and Hispanic Patients With Multiple Sclerosis Enrolled in the CHIMES Trial
Amezcua L, Okai A, Cross A, Monson NL, Thrower BW, Reder AT, English J, Wu GF, Bernitsas E, Yap S, Ndrio J, Pei J, Mowry E, Magrini F, Acosta J, Williams MJ

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 20mins Gaylord National Resort & Convention Center Woodrow Wilson D
Benefits of Repeated Confirmed Disability Progressions Analyses in MS Clinical Trials: A Case Study Using the OPERA and ORATORIO Trials and Their Open-Label Extensions
Wolinsky JS, Hartung HP, Hauser SL, Naismith R, Schneble HM, Townsend B, Wang Q, Kappos L

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:10 PM
Duration 20mins Gaylord National Resort & Convention Center Woodrow Wilson D
Perceptions and Discussions on the Use of Disease-Modifying Therapies During Family Planning in Women With Multiple Sclerosis
Riley Bove, Noemi Pasquarelli, Marina Gafarova, Christine Eighteen, Natalie Joschko, Corey Mandel, Ruth Dobson

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar